| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |